Evidence on antipsychotic drug treatment for schizophrenia from Western and Chinese trials

Evidence on antipsychotic drug treatment for schizophrenia from Western and Chinese trials: building a joint database and applying network meta-analyses.

Approximately one third of controlled schizophrenia trials nowadays come from China. Unfortunately, it is often not clear whether appropriate randomisation and blinding methods were used. We are trying to elucidate this issue with a joint project with Shanghai Mental Health Center funded by a joint Sino-German grant and plan to conduct joint network meta-analyses on efficacy and safety of antipsychotics using the joint database.

Funding: German Research Foundation (DFG; 468853597) and National Natural Science Foundation of China (NSFC; 8216113802).

Protocol: PROSPERO

Contact: Prof. Stefan Leucht